Search

Search Constraints

You searched for: Author/Creator Shamji, Mohamed

Search Results

1. Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes. Issue 1 (December 2015)

3. EAACI Biologicals Guidelines—Recommendations for severe asthma. Issue 1 (10th August 2020)

4. AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper. Issue 9 (14th March 2022)

5. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases. Issue 11 (2nd June 2019)

7. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (18th May 2020)

8. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (24th February 2020)

9. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Issue 5 (1st April 2020)

10. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice. Issue 1 (23rd October 2020)